Three Months Ended March 31,

Six Months Ended March 31,

(In thousands)

2024

2023

2024

2023

Revenue:

Medical Device

$

24,826

$

19,707

$

48,371

$

38,725

In Vitro Diagnostics

7,132

7,491

14,139

13,406

Total revenue

$

31,958

$

27,198

$

62,510

$

52,131

Operating income (loss):

Medical Device

$

302

$

(7,059

)

$

78

$

(14,294

)

In Vitro Diagnostics

3,356

3,636

6,480

6,584

Total segment operating income (loss)

3,658

(3,423

)

6,558

(7,710

)

Corporate

(2,999

)

(3,160

)

(6,221

)

(6,102

)

Total operating income (loss)

$

659

$

(6,583

)

$

337

$

(13,812

)

Depreciation and amortization:

Medical Device

$

1,916

$

1,933

$

3,970

$

3,886

In Vitro Diagnostics

96

75

193

152

Corporate

84

84

266

176

Total depreciation and amortization

$

2,096

$

2,092

$

4,429

$

4,214